Inventor
WANG GARY T
US41 patents
⚠️ This page may combine multiple inventors who share the name “WANG GARY T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE INC
10 patentsUS9174982B2Nov 3, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC38 citations98
US9029404B2May 12, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations92
US9303025B2Apr 5, 2016
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC11 citations84
US9125913B2Sep 8, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC10 citations84
US9073855B2Jul 7, 2015
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9072748B2Jul 7, 2015
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9045420B2Jun 2, 2015
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
ABBVIE INC11 citations84
US9034875B2May 19, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC19 citations84
US11897864B2Feb 13, 2024
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations62
US9156856B2Oct 13, 2015
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
ABBVIE INC0 citations52
ABBOTT LAB
10 patentsUS7772231B2Aug 10, 2010
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors
ABBOTT LAB68 citations95
US6455571B1Sep 24, 2002
Inhibitors of neuraminidases
ABBOTT LAB60 citations95
US7491718B2Feb 17, 2009
Sulfonamides having antiangiogenic and anticancer activity
ABBOTT LAB35 citations90
US6593314B1Jul 15, 2003
Neuraminidase inhibitors
ABBOTT LAB8 citations71
US5877334AMar 2, 1999
Intermediates useful in solid phase synthesis method
ABBOTT LAB2 citations63
US7056925B2Jun 6, 2006
Urea kinase inhibitors
ABBOTT LAB2 citations62
US6518305B1Feb 11, 2003
Five-membered carbocyclic and heterocyclic inhibitors of neuraminidases
ABBOTT LAB6 citations62
US6831096B2Dec 14, 2004
Inhibitors of neuraminidases
ABBOTT LAB3 citations61
US5942632AAug 24, 1999
Solid phase synthesis method
ABBOTT LAB1 citations52
US8354422B2Jan 15, 2013
Pyrimidine inhibitors of kinase activity
ABBOTT LAB2 citations50
VALENT BIOSCIENCES CORP
5 patentsUS9872492B2Jan 23, 2018
(S)-abscisic acid derivatives for thinning
VALENT BIOSCIENCES CORP2 citations71
US9447015B1Sep 20, 2016
(S)-2′-vinyl-abscisic acid derivatives
VALENT BIOSCIENCES CORP5 citations68
US9877480B2Jan 30, 2018
(S)-abscisic acid derivatives for enhanced grape coloration
VALENT BIOSCIENCES CORP1 citations50
US10314307B2Jun 11, 2019
(S)-abscisic acid derivatives for improving plant stress tolerance
VALENT BIOSCIENCES CORP0 citations49
US9781930B2Oct 10, 2017
3′-substituted-abscisic acid derivatives
VALENT BIOSCIENCES CORP0 citations45
VALENT BIOSCIENCES LLC
4 patentsUS10729135B2Aug 4, 2020
Methods of controlling pests using terpendoles
VALENT BIOSCIENCES LLC1 citations57
US11497214B2Nov 15, 2022
Methods of controlling pests using terpendoles
VALENT BIOSCIENCES LLC0 citations56
US10945443B2Mar 16, 2021
Tolypocladium album strain
VALENT BIOSCIENCES LLC1 citations56
US10299476B2May 28, 2019
3′-substituted-abscisic acid derivatives
VALENT BIOSCIENCES LLC0 citations48
BRUNCKO MILAN
3 patentsUS8586754B2Nov 19, 2013
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN59 citations97
US8563735B2Oct 22, 2013
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
BRUNCKO MILAN72 citations97
US8546399B2Oct 1, 2013
Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
BRUNCKO MILAN100 citations97
DOHERTY GEORGE A
2 patentsICOS CORP
2 patentsUS6787542B2Sep 7, 2004
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
ICOS CORP19 citations90
US7129247B2Oct 31, 2006
Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
ICOS CORP3 citations60